K., Lingvay, I., Macura, S.,
Certain techniques produce lighter, more digestible meals that sit better in a stomach slowed by GLP-1 receptor agonists
There are indirect costs, too
And even though its relatively minor compared to the possibility of ongoing nausea or headaches, constantly feeling run down may impact your lifestyle
In June 2025, MBX Biosciences In announced it received preliminary feedback from the FDA on its planned Type B pre-IND meeting, supporting the advancement of its EL-22 program in combination with GLP-1 receptor agonists toward a Phase 2 clinical trial
Learning to recognize and respect these new, sometimes more subtle, signals of fullness is essential